FDA approval of exenatide, its first generic injectable GLP-1 agonist, Amneal (2024) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) first generic GLP-1 indicated for weight loss, Teva Pharmaceuticals (2025) Exenatide, DailyMed (2025) Byetta, DailyMed (2025) Liraglutide (generic Victoza), DailyMed (2025) Liraglutide (generic Saxenda), DailyMed (2025) Victoza, DailyMed (2025) Saxenda, DailyMed (2025) Compounding and the FDA: Questions and answers, U.S
In individuals without dyslexia, language-related brain regions showed clear signs of adaptation when the same voice was repeated but not when different voices were used
Supporting better mood and emotional stability may indirectly contribute to more mindful eating and fewer cravings
Thankfully, it looks very safe, Drucker says, but scientists still need to do longer-term studies in larger groups of people
To lower costs While prices have come down from their peak, GLP-1 drugs aren't exactly cheap
